Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease

K Matsushita, SH Ballew, AYM Wang… - Nature Reviews …, 2022 - nature.com
Chronic kidney disease (CKD) is defined by a low glomerular filtration rate or high
albuminuria, and affects 15–20% of adults globally. CKD increases the risk of various …

The sympathetic nervous system alterations in human hypertension

G Grassi, A Mark, M Esler - Circulation research, 2015 - Am Heart Assoc
Several articles have dealt with the importance and mechanisms of the sympathetic nervous
system alterations in experimental animal models of hypertension. This review addresses …

The autonomic nervous system and hypertension

G Mancia, G Grassi - Circulation research, 2014 - Am Heart Assoc
Physiological studies have long documented the key role played by the autonomic nervous
system in modulating cardiovascular functions and in controlling blood pressure values …

Hypertension in chronic kidney disease

SM Hamrahian, B Falkner - Hypertension: from basic research to clinical …, 2017 - Springer
Hypertension, a global public health problem, is currently the leading factor in the global
burden of disease. It is the major modifiable risk factor for heart disease, stroke and kidney …

Hypertension in chronic kidney disease: What lies behind the scene

OZ Ameer - Frontiers in pharmacology, 2022 - frontiersin.org
Hypertension is a frequent condition encountered during kidney disease development and a
leading cause in its progression. Hallmark factors contributing to hypertension constitute a …

Early sympathetic activation in the initial clinical stages of chronic renal failure

G Grassi, F Quarti-Trevano, G Seravalle, F Arenare… - …, 2011 - Am Heart Assoc
Direct and indirect indices of neuroadrenergic function have shown that end-stage renal
disease is characterized by a marked sympathetic overdrive. It is unknown, however …

Independent association between 1, 25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin–angiotensin system: the Ludwigshafen Risk and Cardiovascular …

A Tomaschitz, S Pilz, E Ritz, T Grammer, C Drechsler… - Clinica chimica acta, 2010 - Elsevier
BACKGROUND: Antihypertensive and tissue-protective properties of vitamin D metabolites
are increasingly attributed to the inhibition of renin synthesis by 1, 25-dihydroxyvitamin D [1 …

[HTML][HTML] Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment

J Neumann, G Ligtenberg, II Klein, HA Koomans… - Kidney international, 2004 - Elsevier
Sympathetic hyperactivity in chronic kidney disease: Pathogenesis, clinical relevance, and
treatment. Cardiovascular morbidity and mortality importantly influence live expectancy of …

Sympathetic overactivity in chronic kidney disease: consequences and mechanisms

J Kaur, BE Young, PJ Fadel - International journal of molecular sciences, 2017 - mdpi.com
The incidence of chronic kidney disease (CKD) is increasing worldwide, with more than 26
million people suffering from CKD in the United States alone. More patients with CKD die of …

[图书][B] Brenner and Rector's The Kidney E-Book

MW Taal, GM Chertow, PA Marsden, K Skorecki… - 2011 - books.google.com
Overcome the toughest clinical challenges in nephrology with the new 9th edition of
Brenner/Rector's The Kidney! A brand-new editorial team of Drs. Maarten W. Taal, Glenn M …